ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

$2.15
-0.12 (-5.29%)
As of Mar 29, 10:42 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +952.1% upside
Low Target $15.82
Average Target $22.62
High Target $24.89
Current Price $2.15
Current
$2.15
Target
$22.62
$15.82 $22.62 avg $24.89
Scenario Analysis
Bear Case
$15.82
635.8%
Low target
Base Case
$22.62
+952.1%
Avg target
Bull Case
$24.89
+1,057.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$11.99
-82.1% from high
52-Week Low
$2.15
+0.0% from low
Target vs 52W High
$22.62
+88.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%